European Archives - Page 454 of 899 - European Medical Journal

Initial Results of the COVID-19 Global Rheumatology Alliance Provider Registry

Initial Results of the COVID-19 Global Rheumatology Alliance Provider Registry

COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of particular concern to patients who are immunocompromised…

NRAS: 'Being Diagnosed with Rheumatoid Arthritis'

New Evidence Linking Gout and Risk of Heart Failure

GOUT has been linked to increased risk of incident heart failure in older adults according to a recent study by Dr Lisandro Colantonio and colleagues…

Antibody Therapies for Patients With Diffuse Large B-cell Lymphoma: What Does the Future Hold?

EMJ Hematology 8 [Suppl 2] 2020

Diffuse large B-cell lymphoma (DLBCL) was considered an incurable disease until the introduction of polychemotherapy…

Antibody Therapies for Patients With Diffuse Large B-cell Lymphoma: What Does the Future Hold?

Antibody Therapies for Patients With Diffuse Large B-cell Lymphoma: What Does the Future Hold?

Prof Sehn opened the symposium with an overview of diffuse large B-cell lymphoma (DLBCL) focussing on key milestones in treatment developments…

Artificial Intelligence May Provide Objective Means of Chest Scan Evaluation

Artificial Intelligence May Provide Objective Means of Chest Scan Evaluation

ARTIFICIAL intelligence could be used as a crucial tool for clear, objective assessment of lung disease to aid radiologists in what has been a measured…

Imaging Data Poses the Question: Is COVID-19 More Than a Lung Infection?

Imaging Data Poses the Question: Is COVID-19 More Than a Lung Infection?

RAISED blood levels of D-dimer have been strongly associated with poor prognosis of coronavirus causing experts to investigate and provide guidance…

Jonathan Sackier and Steven D. Wexner Interview: ICDS

Dr Jonathan Sackier sat down with Prof Steve Wexner, organiser of the highly successful 2020 International Colorectal DIsease Symposium in Jerusalem…

Sebaceous Carcinoma: A Rare Extraocular Presentation of the Cheek

Sebaceous carcinoma is a rare and very aggressive malignant skin cancer of the sebaceous gland. While sebaceous glands are present all over the body…

Best supporting role: patient organisations

In pharma’s bid to be patient centric, it must bring the patient voice to the drug development process with the help of medical affairs.

Integrating wellness into pharma's patient approach

The transition from reactive to proactive treatments correlates with society’s new-found focus on well-being, and the pharma industry must embrace wellness and adapt to steamroll this into improved overall outcomes for patients.